Literature DB >> 21576369

Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity.

Flávia R G Carneiro1, Renata Ramalho-Oliveira, Giuliana P Mognol, João P B Viola.   

Abstract

The nuclear factor of activated T cells (NFAT) family of transcription factors is expressed in a wide range of cell types and regulates genes involved in cell cycle, differentiation, and apoptosis. NFAT proteins share two well-conserved regions, the regulatory domain and the DNA binding domain. The N- and C-terminal ends are transactivation sites and show less sequence similarity, whereas their molecular functions remain poorly understood. Here, we identified a transcriptional repressor, interferon regulatory factor 2 binding protein 2 (IRF-2BP2), which specifically interacts with the C-terminal domain of NFAT1 among the NFAT family members. IRF-2BP2 was described as a corepressor by inhibiting both enhancer-activated and basal transcription. Gene reporter assays demonstrated that IRF-2BP2 represses the NFAT1-dependent transactivation of NFAT-responsive promoters. The ectopic expression of IRF-2BP2 in CD4 T cells resulted in decreased interleukin-2 (IL-2) and IL-4 production, supporting a repressive function of IRF-2BP2 for NFAT target genes. Furthermore, NFAT1 and IRF-2BP2 colocalized in the nucleus in activated cells, and the mutation of a newly identified nuclear localization signal in the IRF-2BP2 rendered it cytoplasmic, abolishing its repressive effect on NFAT1 activity. Collectively, our data demonstrate that IRF-2BP2 is a negative regulator of the NFAT1 transcription factor and suggest that NFAT1 repression occurs at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576369      PMCID: PMC3133407          DOI: 10.1128/MCB.00974-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

Review 1.  Flexible nets. The roles of intrinsic disorder in protein interaction networks.

Authors:  A Keith Dunker; Marc S Cortese; Pedro Romero; Lilia M Iakoucheva; Vladimir N Uversky
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

2.  A strategy for probing the function of noncoding RNAs finds a repressor of NFAT.

Authors:  A T Willingham; A P Orth; S Batalov; E C Peters; B G Wen; P Aza-Blanc; J B Hogenesch; P G Schultz
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

3.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT.

Authors:  Merav Yoeli-Lerner; Gary K Yiu; Isaac Rabinovitz; Peter Erhardt; Sebastien Jauliac; Alex Toker
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

4.  NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.

Authors:  Gary K Yiu; Alex Toker
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

5.  Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

Authors:  Wenfang Wu; Ravi S Misra; Jennifer Q Russell; Richard A Flavell; Mercedes Rincón; Ralph C Budd
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

Review 6.  Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.

Authors:  Mikael S Lindström; Chad Deisenroth; Yanping Zhang
Journal:  Cell Cycle       Date:  2007-02-18       Impact factor: 4.534

7.  IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation.

Authors:  Leonardo K Teixeira; Bruna P F Fonseca; Adriana Vieira-de-Abreu; Bianca A Barboza; Bruno K Robbs; Patrícia T Bozza; João P B Viola
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

8.  Spectroscopic characterization of the tumor antigen NY-REN-21 and identification of heterodimer formation with SCAND1.

Authors:  Flávia R G Carneiro; Tereza C L Silva; Adriana C Alves; Thais Haline-Vaz; Fabio C Gozzo; Nilson I T Zanchin
Journal:  Biochem Biophys Res Commun       Date:  2006-03-03       Impact factor: 3.575

9.  Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers.

Authors:  Yan Wang; Dong-Ping Liu; Ping-Ping Chen; H Phillip Koeffler; Xiang-Jun Tong; Dong Xie
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

View more
  28 in total

1.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

2.  Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.

Authors:  C Cameron Yin; Nitin Jain; Meenakshi Mehrotra; Jianhua Zhagn; Alexei Protopopov; Zhuang Zuo; Naveen Pemmaraju; Courtney DiNardo; Cheryl Hirsch-Ginsberg; Sa A Wang; L Jeffrey Medeiros; Lynda Chin; Keyur P Patel; Farhad Ravandi; Andrew Futreal; Carlos E Bueso-Ramos
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

3.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

Authors:  Christian H Gabriel; Fridolin Gross; Martin Karl; Heike Stephanowitz; Anna Floriane Hennig; Melanie Weber; Stefanie Gryzik; Ivo Bachmann; Katharina Hecklau; Jürgen Wienands; Johannes Schuchhardt; Hanspeter Herzel; Andreas Radbruch; Eberhard Krause; Ria Baumgrass
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

4.  Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.

Authors:  Michael D Keller; Rahul Pandey; Dong Li; Joseph Glessner; Lifeng Tian; Sarah E Henrickson; Ivan K Chinn; Linda Monaco-Shawver; Jennifer Heimall; Cuiping Hou; Frederick G Otieno; Soma Jyonouchi; Leonard Calabrese; Joris van Montfrans; Jordan S Orange; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2016-03-23       Impact factor: 10.793

5.  IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.

Authors:  Samir Mazharuddin; Anuja Chattopadhyay; Moshe Y Levy; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2018-01-19

6.  Human Hepatocyte Nuclear Factor 4-α Encodes Isoforms with Distinct Transcriptional Functions.

Authors:  Élie Lambert; Jean-Philippe Babeu; Joël Simoneau; Jennifer Raisch; Laurie Lavergne; Dominique Lévesque; Émilie Jolibois; Mariano Avino; Michelle S Scott; François Boudreau; Francois-Michel Boisvert
Journal:  Mol Cell Proteomics       Date:  2020-03-02       Impact factor: 5.911

7.  IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.

Authors:  Song Gao; Yan Sun; Xuebin Zhang; Limei Hu; Yuexin Liu; Corrine Yingxuan Chua; Lynette M Phillips; He Ren; Jason B Fleming; Huamin Wang; Paul J Chiao; Jihui Hao; Wei Zhang
Journal:  Cancer Res       Date:  2016-09-22       Impact factor: 12.701

8.  IRF2BP2: A New Player at the Crossroads of Inflammation and Lipid Metabolism.

Authors:  Hanrui Zhang; Muredach P Reilly
Journal:  Circ Res       Date:  2015-09-25       Impact factor: 17.367

9.  Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.

Authors:  Yasuharu Sato; Hiroaki Miyoshi; Kana Sakamoto; Yosaku Watatani; Kenji Nishida; Yuka Gion; Yasunobu Nagata; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Lanying Zhao; Yotaro Ochi; Yasuhide Takeuchi; June Takeda; Hiroo Ueno; Yasunori Kogure; Yusuke Shiozawa; Nobuyuki Kakiuchi; Tetsuichi Yoshizato; Masahiro M Nakagawa; Yasuhito Nanya; Kenichi Yoshida; Hideki Makishima; Masashi Sanada; Mamiko Sakata-Yanagimoto; Shigeru Chiba; Ryota Matsuoka; Masayuki Noguchi; Nobuhiro Hiramoto; Takayuki Ishikawa; Junichi Kitagawa; Nobuhiko Nakamura; Hisashi Tsurumi; Tatsuhiko Miyazaki; Yusuke Kito; Satoru Miyano; Kazuya Shimoda; Kengo Takeuchi; Koichi Ohshima; Tadashi Yoshino; Seishi Ogawa; Keisuke Kataoka
Journal:  Leukemia       Date:  2019-05-15       Impact factor: 11.528

10.  NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death.

Authors:  Douglas V Faget; Pedro I Lucena; Bruno K Robbs; João P B Viola
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.